Intapharm Laboratories Limited in Maidstone, ME14 3EN

Description

Data updated on: 01-11-2023

The Intapharm Laboratories Limited firm has been operating in this business for at least seven years, having started in 2017. Started with Registered No. 10842035, Intapharm Laboratories is a Private Limited Company with office in Globe House Eclipse Park, Maidstone ME14 3EN. This enterprise's registered with SIC code 21200 - Manufacture of pharmaceutical preparations. Intapharm Laboratories Ltd reported its latest accounts for the period that ended on 30th June 2022. The business latest confirmation statement was released on 28th June 2023.

At the moment, this particular company is directed by just one director: Mehdi M., who was arranged to perform management duties seven years ago.

Mehdi M. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30
Currency

Balance Sheet
Cash Bank On Hand	2 075	3 373	3 336	3 017	2 897	2 789
Current Assets	1 697 839	950 592	216 992	219 562	221 226	221 845
Debtors	1 021 949	2 935	4 538	7 427	9 211	9 938
Net Assets Liabilities	-117 032	-122 345
Other Debtors	1 121	2 935	4 539	7 427	9 211	9 938
Total Inventories	673 815	944 284	209 118	209 118	209 118

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets	125 612	376 835	502 446	502 446	502 446
Additions Other Than Through Business Combinations Intangible Assets	502 446
Amounts Owed To Group Undertakings		486 185	412 021	412 021	412 021	412 021
Average Number Employees During Period	1	1	1	1	1	1
Creditors	486 185	1 198 548	508 750	533 753	551 223	564 457
Dividends Paid On Shares	376 834	125 611
Increase From Amortisation Charge For Year Intangible Assets	125 612	251 223	125 611
Intangible Assets	376 834	125 611
Intangible Assets Gross Cost	502 446	502 446	502 446	502 446	502 446
Net Current Assets Liabilities	-7 681	-247 956	-291 758	-314 191	-329 997
Other Creditors	486 185	63 778	89 996	119 649	139 202	149 076
Total Assets Less Current Liabilities	369 153	-122 345	-291 758
Trade Creditors Trade Payables	1 662 941	648 585	6 733	2 083		3 360
Trade Debtors Trade Receivables	1 020 828		-1

Company staff

Mehdi M.

Role: Director

Appointed: 29 June 2017

Latest update: 27 March 2024

People with significant control

Mehdi M.

Notified on 29 June 2017

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	29 March 2024
Account last made up date	30 June 2022
Confirmation statement next due date	12 July 2024
Confirmation statement last made up date	28 June 2023

Annual Accounts
Start Date For Period Covered By Report	2017-06-29
End Date For Period Covered By Report	2018-06-30
Annual Accounts
Start Date For Period Covered By Report	2018-07-01
End Date For Period Covered By Report	2019-06-30
Annual Accounts
Start Date For Period Covered By Report	2019-07-01
End Date For Period Covered By Report	2020-06-30
Annual Accounts
Start Date For Period Covered By Report	2020-07-01
End Date For Period Covered By Report	2021-06-30
Annual Accounts
Start Date For Period Covered By Report	2021-07-01
End Date For Period Covered By Report	2022-06-30
Annual Accounts
Start Date For Period Covered By Report	2022-07-01
End Date For Period Covered By Report	2023-06-30

Intapharm Laboratories Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mehdi M.

People with significant control

Mehdi M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest companies